Making decisions about hormone replacement therapy: Preparations containing oestrogen should not be given during treatment for breast cancer

BMJ 2003; 326 doi: 10.1136/bmj.326.7403.1398 (Published 19 June 2003)
Cite this as: BMJ 2003;326:1398.1

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

Access to the full text of this article requires a subscription or payment

Article access

Article access for 1 day

Purchase this article for £20 $30 €32*

The PDF version can be downloaded as your personal record

* Prices do not include VAT

THIS WEEK'S POLL